Successful treatment of T-γ lymphoproliferative disease with human-recombinant granulocyte colony stimulating factor

This publication has 9 references indexed in Scilit:

• Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-γ lymphoproliferative disease
  American Journal of Hematology, 1991
• DIFFERENTIAL EFFECT OF G-CSF AND GM-CSF IN ACQUIRED CHRONIC NEUTROPENIA
  British Journal of Haematology, 1991
• AGRANULOCYTOSIS ASSOCIATED WITH GRANULAR LYMPHOCYTE LEUKAEMIA: IMPROVEMENT OF PERIPHERAL BLOOD GRANULOCYTE COUNT WITH HUMAN RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF)
  British Journal of Haematology, 1990
• Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms
  Blood, 1989
• Clinical Use of Recombinant Human Hematopoietic Growth Factors
  JNCI Journal of the National Cancer Institute, 1989
• AGRANULOCYTOSIS ASSOCIATED WITH T‐GAMMA‐LYMPHOCYTOSIS: NO IMPROVEMENT OF PERIPHERAL BLOOD GRANULOCYTE COUNT WITH HUMAN‐RECOMBINANT GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (GM‐CSF)
  British Journal of Haematology, 1989
• Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes
  Blood, 1986
• T gamma-lymphoproliferative disease and related disorders in humans and experimental animals: a review of the clinical, cellular, and functional characteristics
  Blood, 1984
• T lymphocytes involved in inhibition of granulopoiesis in two neutropenic patients are of the cytotoxic/suppressor (T3+T8+) subset.
  Journal of Clinical Investigation, 1981